Back | Next |
home / stock / albo / albo message board
Subject | By | Source | When |
---|---|---|---|
Albireo now expects to plan the path for | cashcow3 | investorshub | 12/22/2016 11:24:55 AM |
http://cincysportszone.com/stock-sputtering-pre-bell-gapping-down-albireo-pharma | cashcow3 | investorshub | 12/22/2016 11:12:15 AM |
new FORM 8-K | cashcow3 | investorshub | 12/22/2016 10:27:42 AM |
Same recent movement has me cringing afternI added.. | Ross92 | investorshub | 12/22/2016 4:49:42 AM |
Biod days. | beeboispiggs | investorshub | 12/21/2016 10:21:06 PM |
That would be awesome. I've been waiting on | Ross92 | investorshub | 12/18/2016 10:36:42 PM |
If we could get some analyst coverage it | beeboispiggs | investorshub | 12/18/2016 10:00:41 PM |
Come on alboooooo | Ross92 | investorshub | 12/15/2016 10:16:31 PM |
Looks like we found so solid support around | Ross92 | investorshub | 12/09/2016 6:46:29 AM |
$ALBO bullish 26.90 | stocktrademan | investorshub | 11/23/2016 4:31:04 PM |
With the 30:1 RS, BIOD is now trading | Rymankoly | investorshub | 11/21/2016 5:08:04 PM |
Albireo announced positive top line phase 3 results | Inspector Clouseau | investorshub | 11/17/2016 6:39:24 PM |
The institutions are filing their holdings and they | Inspector Clouseau | investorshub | 11/17/2016 5:36:07 PM |
The spike today? What is it from..!?! I | Ross92 | investorshub | 11/17/2016 3:40:08 PM |
There is about 8 million shares outstanding which | Inspector Clouseau | investorshub | 11/16/2016 4:09:34 PM |
A 10 bagger? For real?? I like the | Ross92 | investorshub | 11/16/2016 3:51:06 PM |
$ALBO CHARTS | PIRAT | investorshub | 11/16/2016 1:17:44 PM |
I think it depends on how this plays | Inspector Clouseau | investorshub | 11/16/2016 7:41:04 AM |
What could the pps possibly go to though.. | Ross92 | investorshub | 11/16/2016 5:21:11 AM |
$ALBO up 12%+ on EMA (PRIME) acceptance | djpope | investorshub | 11/15/2016 9:40:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Albireo Pharma Inc. Company Name:
ALBO Stock Symbol:
NASDAQ Market:
Bylvay (odevixibat) granted Priority Review by U.S. FDA ASSERT study demonstrated efficacy of Bylvay in pruritus, bile acids and sleep with a low drug-related diarrhea rate in Alagille patients Approval in second indication would more than double Bylvay market oppo...
NEW YORK, NY / ACCESSWIRE / February 9, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Trean Insurance Group, Inc. (NASDA...
NEW YORK, NY / ACCESSWIRE / February 8, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Oak Street Health, Inc. (NYSE:OSH)'s ...